Vilin Bio Med Limited IPO: Issue Price, Listing Gain and Share Price Now
Vilin Bio Med Limited listed on 30-Jun-2023 at ₹28.5 against an issue price of ₹30 , a listing change of -5.00%. It last traded at ₹41.1. This page is the record of that issue and what has happened to it since — reported figures only.
Vilin Bio Med Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹30 |
| Listing price (listing-day close) | ₹28.5 |
| Listing gain | -5.00% |
| Price now | ₹41.1 |
| Change from issue price | +37.00% |
| Change from listing-day close | +44.21% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Vilin Bio Med Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹30 |
| Issue size | ₹11.38 Cr |
| Fresh issue | ₹11.38 Cr |
| Issue opened | 16-Jun-2023 |
| Issue closed | 21-Jun-2023 |
| Listed on | 30-Jun-2023 |
| Exchange | NSE SME |
| Segment | SME |
| Lead managers | Inventure Merchant Banker (left lead) |
How the Vilin Bio Med Limited IPO was subscribed
| Category | Subscription |
|---|---|
| NII | 1.28x |
| Retail | 4.31x |
| Total | 2.80x |
Vilin Bio Med Limited today
| Figure | Value |
|---|---|
| Sector | Pharmaceuticals |
Fundamentals are as of the desk's last harvest and move with the market.
- Vilin Bio Med Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.